Comparison of Robotic Versus Laparoscopic Surgery for Visceral Obesity in Mid-Low Rectal Cancer: A Propensity-Matched Analysis
1 other identifier
observational
242
1 country
1
Brief Summary
Our team has previously published articles providing detailed descriptions of the steps involved in both RS and LS. All surgeries adhered to the total mesorectal excision (TME) principle. In RS, a surgeon employed the Da Vinci Xi surgical system featuring a five-port setup, while five physicians conducted LS with a similarly configured five-port approach. Both the RS and LS doctors are experienced. The surgeries were conducted according to standard procedures, and the RS group utilized totally robotic rectal resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 29, 2024
CompletedFirst Submitted
Initial submission to the registry
April 29, 2024
CompletedFirst Posted
Study publicly available on registry
May 2, 2024
CompletedMay 2, 2024
April 1, 2024
3.9 years
April 29, 2024
April 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
early postoperative problems
early postoperative problems
2019-2023
Study Arms (2)
laparoscopic surgery with visceral obesity
robotic surgery with visceral obesity
Interventions
robotic surgery
Eligibility Criteria
This retrospective investigation included participants who experienced anterior rectal resection using robotic or laparoscopic techniques at the General Surgery Department of Northern Jiangsu People's Hospital between December 2019 and October 2023.
You may qualify if:
- (1) confirmed pathology of mid-to-low rectal cancer (within 10 centimeters from the anal margin); (2) availability of comprehensive pathological and computed tomography (CT) data; (3) presence of a diagnosis indicating visceral obesity.
You may not qualify if:
- Multiple tumor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Daorong Wanglead
Study Sites (1)
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, 225001, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
April 29, 2024
First Posted
May 2, 2024
Study Start
December 1, 2019
Primary Completion
October 30, 2023
Study Completion
January 29, 2024
Last Updated
May 2, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share